T-cells — Drug Target
All drugs that target T-cells — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
T-cell therapy · Monoclonal antibody
Marketed (1)
- (H) T-L14 · National Taiwan University Hospital · T-cell therapy · Oncology
T-L14 is a T-cell therapy that enhances anti-tumor immune response.
Phase 3 pipeline (1)
- Rabbit Anti-Human Thymocyte Globulin · Dr. Claudia Bösmüller · Monoclonal antibody · Immunology
Rabbit Anti-Human Thymocyte Globulin works by depleting T lymphocytes, thereby reducing the immune response.